Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2012

Mar 15, 2012

31971_dirs_2012-03-15_5c06a1f9-f541-4591-ae59-d7bc3c937edd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-03-13

Reporting Person: CORASANTI EUGENE R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-13 Common Stock M 112500 $25.89 Acquired 180303 Direct
2012-03-13 Common Stock S 112500 $29.1537 Disposed 67803 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-03-13 Options To Purchase Common Stock $25.89 M 112500 Disposed 2012-05-14 Common Stock (112500) Direct

Footnotes

F1: 5 year vesting schedule, 20% vest each year starting 5/14/2003

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.10 to $29.291. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.